Related Experiment Video
Updated: Jul 14, 2026
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Omega-3 fatty acids and sudden arrhythmic death
Stuart J Connolly1, Jeffrey S Healey
1Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Herz
|June 20, 2007
Summary
Cardiovascular disease, particularly ischemic heart disease, causes significant mortality. Ventricular fibrillation is a major cause of sudden cardiac death in these patients.
Area of Science:
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is the primary cause of death in developed nations.
- In Canada, CVD accounted for 36% of all deaths in 1999, with ischemic heart disease (IHD) being the largest contributor.
- Myocardial infarction (MI) leads to two main complications: impaired myocardial function (congestive heart failure) and cardiac rhythm disturbances (ventricular fibrillation).
Purpose of the Study:
- To highlight the significant impact of ischemic heart disease on mortality.
- To differentiate the tracking and impact of congestive heart failure versus sudden cardiac death.
- To estimate the contribution of ventricular fibrillation to sudden cardiac death in IHD patients.
Main Methods:
- Analysis of administrative databases to track congestive heart failure mortality rates.
- Estimation of sudden cardiac death rates attributed to ventricular fibrillation in IHD patients.
- Review of mortality statistics for developed countries and Canada.
Main Results:
- Ischemic heart disease accounts for 20% of all deaths, with half due to acute myocardial infarction effects and the other half to late complications.
- Congestive heart failure has a tracked annual death rate of approximately 2.5% in Canada.
- Ventricular fibrillation is estimated to cause at least 25% of deaths in patients diagnosed with ischemic heart disease.
Conclusions:
- Myocardial infarction sequelae, including heart failure and ventricular fibrillation, are major contributors to cardiovascular mortality.
- Sudden death due to ventricular fibrillation is difficult to quantify but represents a substantial cause of mortality in IHD.
- Further research is needed to better quantify and address sudden cardiac death in the context of ischemic heart disease.
Related Concept Videos
03:38Structure of Lipids
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...